Shulman Joseph
Reporting owner on Forms 3, 4 and 5, CIK 1909855.
Shulman Joseph reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-11-20.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| RYTM · RHYTHM PHARMACEUTICALS, INC.CIK 1649904 | officer (Chief Technical Officer) | 1 | 2026-11-20 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| RYTM · RHYTHM PHARMACEUTICALS, INC.Common Stock | 2026-11-18 | M exercised | +1,961 | $6.8 | 17,876 | Form 4 |
| RYTM · RHYTHM PHARMACEUTICALS, INC.Common Stock | 2026-11-18 | M exercised | +4,188 | $27.35 | 22,064 | Form 4 |
| RYTM · RHYTHM PHARMACEUTICALS, INC.Common Stock | 2026-11-18 | M exercised | +24,944 | $49.23 | 47,008 | Form 4 |
| RYTM · RHYTHM PHARMACEUTICALS, INC.Common Stock | 2026-11-18 | M exercised | +9,374 | $56.69 | 56,382 | Form 4 |
| RYTM · RHYTHM PHARMACEUTICALS, INC.Common Stock | 2026-11-18 | S sold | -45,921 | $119.9049 | 10,461 | Form 4 |
| RYTM · RHYTHM PHARMACEUTICALS, INC.Stock Options (Right to Buy), derivative | 2026-11-18 | M exercised | -1,961 | $0 | 3,984 | Form 4 |
| RYTM · RHYTHM PHARMACEUTICALS, INC.Stock Options (Right to Buy), derivative | 2026-11-18 | M exercised | -4,188 | $0 | 8,375 | Form 4 |
| RYTM · RHYTHM PHARMACEUTICALS, INC.Stock Options (Right to Buy), derivative | 2026-11-18 | M exercised | -24,944 | $0 | 25,306 | Form 4 |
| RYTM · RHYTHM PHARMACEUTICALS, INC.Stock Options (Right to Buy), derivative | 2026-11-18 | M exercised | -9,374 | $0 | 28,126 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001649904-26-000032 | RHYTHM PHARMACEUTICALS, INC. | 2026-11-20 |